Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2007-10-06 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: WINGEN-SUR-MODER (67290), Bas-Rhin
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SARL PHARMACIE DE WINGEN SUR MODER : revenue, balance sheet and financial ratios
SARL PHARMACIE DE WINGEN SUR MODER is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in WINGEN-SUR-MODER (67290),
this company of category PME
shows in 2023 a net income positive of 39 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SARL PHARMACIE DE WINGEN SUR MODER (SIREN 500827456)
Indicator
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
39 407 €
63 142 €
47 184 €
89 247 €
83 294 €
77 502 €
70 208 €
109 409 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, SARL PHARMACIE DE WINGEN SUR MODER generates positive net income of 39 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 109 k€ -> 39 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
39 407 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 46%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
45.748%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
57.017%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SARL PHARMACIE DE WINGEN SUR MODER
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Debt ratio
207.781
169.125
136.715
109.331
86.156
71.72
53.054
45.748
Financial autonomy
28.248
32.072
37.114
42.132
46.366
50.102
55.117
57.017
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
45.752023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good-5 pts over 3 years
In 2023, the debt ratio of SARL PHARMACIE DE WINGEN ... (45.75) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
57.02%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good
In 2023, the financial autonomy of SARL PHARMACIE DE WINGEN ... (57.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 132.17. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
132.173
Liquidity indicators evolution SARL PHARMACIE DE WINGEN SUR MODER
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
217.599
204.164
174.929
174.084
160.229
168.513
137.716
132.173
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
132.172023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Watch-15 pts over 3 years
In 2023, the liquidity ratio of SARL PHARMACIE DE WINGEN ... (132.17) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of SARL PHARMACIE DE WINGEN SUR MODER in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SARL PHARMACIE DE WINGEN SUR MODER is estimated at
464 981 €
(range 282 777€ - 653 660€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
282k€464k€653k€
464 981 €Range: 282 777€ - 653 660€
NAF 5 année 2023
Valuation method used
Net Income Multiple
39 407 €
×
11.8x
=464 982 €
Range: 282 778€ - 653 660€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SARL PHARMACIE DE WINGEN SUR MODER with other companies in the same sector:
Frequently asked questions about SARL PHARMACIE DE WINGEN SUR MODER
What is the revenue of SARL PHARMACIE DE WINGEN SUR MODER ?
The revenue of SARL PHARMACIE DE WINGEN SUR MODER is not publicly disclosed (confidential accounts filed with INPI).
Is SARL PHARMACIE DE WINGEN SUR MODER profitable?
Yes, SARL PHARMACIE DE WINGEN SUR MODER generated a net profit of 39 k€ in 2023.
Where is the headquarters of SARL PHARMACIE DE WINGEN SUR MODER ?
The headquarters of SARL PHARMACIE DE WINGEN SUR MODER is located in WINGEN-SUR-MODER (67290), in the department Bas-Rhin.
Where to find the tax return of SARL PHARMACIE DE WINGEN SUR MODER ?
The tax return of SARL PHARMACIE DE WINGEN SUR MODER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SARL PHARMACIE DE WINGEN SUR MODER operate?
SARL PHARMACIE DE WINGEN SUR MODER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart